Here's Why You Should Retain IDEXX (IDXX) Stock for Now
https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054
Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance
0
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766
Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
0
Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe
https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631
Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
0
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up
https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769
Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
0
Sight Sciences (SGHT) to Expand in Europe With New Launch
https://www.zacks.com/stock/news/2229444/sight-sciences-sght-to-expand-in-europe-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229444
Feb 21, 2024 - By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
0
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2230219/why-cardinal-health-cah-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2230219
Feb 22, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status
https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299
Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
0
ICON (ICLR) Gains From Strategic Deals, New Innovations
https://www.zacks.com/stock/news/2235446/icon-iclr-gains-from-strategic-deals-new-innovations?cid=CS-ZC-FT-analyst_blog|zer_report_update-2235446
Mar 04, 2024 - ICON (ICLR) continues to evolve its collaboration and delivery models, invest in technology, and enhance its project and program management capabilities.
0
CVS Health (CVS) Expands In-Home Diagnostic Care With New Test
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
0
Page 1>